Schonfeld Strategic Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
17,031
+4,521
| +36% | +$55.5K | ﹤0.01% | 1686 |
|
|
2025
Q1 | $275K | Buy |
+12,510
| New | +$275K | ﹤0.01% | 1700 |
|
|
2024
Q2 | – | Sell |
-10,683
| Closed | -$379K | – | 2153 |
|
|
2024
Q1 | $379K | Sell |
10,683
-15,874
| -60% | -$563K | ﹤0.01% | 1386 |
|
|
2023
Q4 | $1.16M | Buy |
+26,557
| New | +$1.16M | 0.01% | 912 |
|
|
2023
Q3 | – | Sell |
-63,762
| Closed | -$2.62M | – | 1834 |
|
|
2023
Q2 | $2.62M | Buy |
63,762
+58,526
| +1,118% | +$2.41M | 0.02% | 666 |
|
|
2023
Q1 | $301K | Sell |
5,236
-23,623
| -82% | -$1.36M | ﹤0.01% | 1348 |
|
|
2022
Q4 | $1.62M | Sell |
28,859
-87,480
| -75% | -$4.91M | 0.01% | 910 |
|
|
2022
Q3 | $4.93M | Buy |
116,339
+104,359
| +871% | +$4.42M | 0.04% | 530 |
|
|
2022
Q2 | $648K | Sell |
11,980
-24,620
| -67% | -$1.33M | 0.01% | 1151 |
|
|
2022
Q1 | $2.35M | Buy |
+36,600
| New | +$2.35M | 0.02% | 628 |
|
|
2021
Q2 | – | Sell |
-14,900
| Closed | -$1.03M | – | 2052 |
|
|
2021
Q1 | $1.03M | Buy |
+14,900
| New | +$1.03M | 0.01% | 849 |
|
|
2019
Q2 | – | Sell |
-8,280
| Closed | -$461K | – | 1097 |
|
|
2019
Q1 | $461K | Buy |
+8,280
| New | +$461K | 0.02% | 719 |
|
|
2017
Q2 | – | Sell |
-102,087
| Closed | -$4.3M | – | 666 |
|
|
2017
Q1 | $4.3M | Buy |
102,087
+31,465
| +45% | +$1.33M | 0.43% | 57 |
|
|
2016
Q4 | $3.03M | Buy |
+70,622
| New | +$3.03M | 0.39% | 67 |
|